Effects of ECA on Quality of Life in Head and Neck Cancer Patients Suffering From Cetuximab-induced Rhagades

NCT01693159 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Pain

Interventions

DEVICE: ECA
OTHER: Standard topical treatment of the institution, e.g. Lotio

Sponsor

National Center for Tumor Diseases, Heidelberg

Collaborators

[object Object]
[object Object]